Hypertrophic cardiomyopathy: Histopathological features of sudden death in cardiac troponin T disease

Circulation

Volumn 104, Issue 12, 2001, Pages 1380-1384

  Varnava, Amanda M ^a   Elliott, Perry M ^a   Baboonian, Christina ^a   Davison, Fergus ^a   Davies, Michael J ^a   McKenna, William J ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Cardiomyopathy; Hypertrophy; Pathology

Indexed keywords

DNA; TROPONIN T;

ADOLESCENT; ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART WEIGHT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SUDDEN DEATH;

EID: 0035909017     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3701.095952     Document Type: Article

References (27)

1. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere
2. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14ql
3. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation
4. Sudden death due to troponin T mutations
5. Genotype-phenotype correlations in hypertrophic cardiomyopathy: Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations
6. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
7. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene
8. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta- myosin heavy chain gene: A 908Leu-Val mutation and a 403Arg-Gln mutation
9. Characteristics and prognoslic implications of myosin missense mutations in familial hypertrophic cardiomyopathy
10. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy
11. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy
12. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy
13. Experience from clinical genetics in hypertrophic cardiomyopathy proposal for new diagnostic criteria in adult members of affected families
14. A mouse model of familial hypertrophic cardiomyopathy
15. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy
16. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide angle, two dimensional echocardiographic study of 125 patients
17. The current status of myocardial disarray in hypertrophic cardiomyopathy
18. Relation between extent of cardiac muscle cell disorganisation and left ventricular wall thickness in hypertrophic cardiomyopathy
19. Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy
20. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: Insights into disease pathogenesis and troponin function
21. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy
22. Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy
23. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy
24. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy
25. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy
26. Ventricular late potentials interstitial fibrosis, and right ventricular function in patients with ventricular tachycardia and normal left ventricular function
27. Patients with familial hypertrophic cardiomyopathy caused by a PheII0lie missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis